GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Ensign Group Inc (NAS:ENSG) » Definitions » ROE %

Ensign Group (Ensign Group) ROE %

: 5.88% (As of Dec. 2023)
View and export this data going back to 2007. Start your Free Trial

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Ensign Group's annualized net income for the quarter that ended in Dec. 2023 was $87 Mil. Ensign Group's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $1,476 Mil. Therefore, Ensign Group's annualized ROE % for the quarter that ended in Dec. 2023 was 5.88%.

The historical rank and industry rank for Ensign Group's ROE % or its related term are showing as below:

ENSG' s ROE % Range Over the Past 10 Years
Min: 8.53   Med: 16.61   Max: 23.16
Current: 15.16

During the past 13 years, Ensign Group's highest ROE % was 23.16%. The lowest was 8.53%. And the median was 16.61%.

ENSG's ROE % is ranked better than
79.08% of 607 companies
in the Healthcare Providers & Services industry
Industry Median: 4.07 vs ENSG: 15.16

Ensign Group ROE % Historical Data

The historical data trend for Ensign Group's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ensign Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.75 23.16 21.17 19.81 15.29

Ensign Group Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.93 18.66 18.92 17.94 5.88

Competitive Comparison

For the Medical Care Facilities subindustry, Ensign Group's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ensign Group ROE % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Ensign Group's ROE % distribution charts can be found below:

* The bar in red indicates where Ensign Group's ROE % falls into.



Ensign Group ROE % Calculation

Ensign Group's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=209.399/( (1247.332+1491.865)/ 2 )
=209.399/1369.5985
=15.29 %

Ensign Group's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=86.764/( (1459.746+1491.865)/ 2 )
=86.764/1475.8055
=5.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Ensign Group  (NAS:ENSG) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=86.764/1475.8055
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(86.764 / 3921.512)*(3921.512 / 4129.761)*(4129.761 / 1475.8055)
=Net Margin %*Asset Turnover*Equity Multiplier
=2.21 %*0.9496*2.7983
=ROA %*Equity Multiplier
=2.1 %*2.7983
=5.88 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=86.764/1475.8055
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (86.764 / 125.128) * (125.128 / 91.304) * (91.304 / 3921.512) * (3921.512 / 4129.761) * (4129.761 / 1475.8055)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.6934 * 1.3705 * 2.33 % * 0.9496 * 2.7983
=5.88 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Ensign Group ROE % Related Terms

Thank you for viewing the detailed overview of Ensign Group's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ensign Group (Ensign Group) Business Description

Traded in Other Exchanges
Address
29222 Rancho Viejo Road, Suite 127, San Juan Capistrano, CA, USA, 92675
Ensign Group Inc provides post-acute healthcare services in the United States. Its regional subsidiaries oversee skilled nursing, assisted living, home health and hospice, mobile ancillary, and urgent care operations. Medicare and Medicaid programs contribute a majority of revenue received for Ensign's services. The firm operates through two segments, Skilled services, and Standard Bearer. The skilled services segment includes the operation of skilled nursing facilities and rehabilitation therapy services. The real estate segment comprises of properties owned by the company and leased to skilled nursing and assisted living operations. The majority of the revenue is generated from the services segment.
Executives
Daren Shaw director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Spencer Burton officer: President and COO 29222 RANCHO VIEJO ROAD, SUITE 127, SAN JUAN CAPISTRANO CA 92675
Ann Scott Blouin director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Chad Keetch officer: Executive Vice President 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Christopher R. Christensen director, 10 percent owner, officer: President & CEO 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Suzanne D. Snapper officer: CFO 27101 PUERTA REAL, STE 450, MISSION VIEJO CA 92691
John O Agwunobi director 4800 NORTH SCOTTSDALE ROAD, SCOTTSDALE AZ 85251
Lee A Daniels director 5152 N. EDGEWOOD DRIVE, SUITE 375, PROVO UT 84604
Beverly B. Wittekind officer: VP & General Counsel 27101 PUERTA REAL, STE 450, MISSION VIEJO CA 92691
Barry Port officer: President of a subsidiary 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
John G. Nackel director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Swati Bargotra Abbott director 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251
Antoinette T. Hubenette director 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691
Malene Davis director 50 F. STREET, NW, SUITE 3300, WASHINGTON DC 92691
Roy E Christensen director, 10 percent owner, officer: Chairman of the Board 27101 PUERTA REAL, SUITE 450, MISSION VIEJO CA 92691

Ensign Group (Ensign Group) Headlines